Showing 1 - 4 results of 4 for search 'Garlapati, R', query time: 0.41s
Refine Results
-
1
Azithromycin for mild-to-moderate COVID-19: author's reply by Hinks, TSC, Cureton, L, Knight, R, Wang, A, Cane, JL, Barber, VS, Black, J, Dutton, SJ, Melhorn, J, Jabeen, M, Moss, P, Garlapati, R, Baron, T, Johnson, G, Cantle, F, Clarke, D, Elkhodair, S, Underwood, J, Lasserson, D, Pavord, ID, Morgan, S, Richards, D
Published 2021Journal article -
2
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial by Hinks, TSC, Cureton, L, Knight, R, Wang, A, Cane, JL, Barber, VS, Black, J, Dutton, SJ, Melhorn, J, Jabeen, M, Moss, P, Garlapati, R, Baron, T, Johnson, G, Cantle, F, Clarke, D, Elkhodair, S, Underwood, J, Lasserson, D, Pavord, ID, Morgan, S, Richards, D
Published 2021Journal article -
3
A randomised clinical trial of azithromycin versus standard care in ambulatory COVID-19 – the ATOMIC2 trial by Hinks, TSC, Cureton, L, Knight, R, Wang, A, Cane, JL, Barber, VS, Black, J, Dutton, SJ, Melhorn, J, Jabeen, M, Moss, P, Garlapati, R, Baron, T, Johnson, G, Cantle, F, Clarke, D, Elkhodair, S, Underwood, J, Lasserson, D, Pavord, ID, Morgan, SB, Richards, D
Published 2021Conference item -
4
Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India by Cameron, M, Acosta-Serrano, A, Bern, C, Boelaert, M, Den Boer, M, Burza, S, Chapman, L, Chaskopoulou, A, Coleman, M, Courtenay, O, Croft, S, Das, P, Dilger, E, Foster, G, Garlapati, R, Haines, L, Harris, A, Hemingway, J, Hollingsworth, T, Jervis, S, Medley, G, Miles, M, Paine, M, Picado, A, Poché, R, Ready, P, Rogers, M, Rowland, M, Sundar, S, De Vlas, S, Weetman, D
Published 2016Journal article